I spent 3 days with pharma executives. They're suddenly taking longevity seriously.
For decades, “longevity” was a word serious drug makers avoided. It conjured images of supplement gurus, Silicon Valley biohackers, and
Read MoreFor decades, “longevity” was a word serious drug makers avoided. It conjured images of supplement gurus, Silicon Valley biohackers, and
Read MoreGoldman Sachs is betting that professionals who counsel the wealthy will have a strong future in the age of AI.
Read MoreDave Castino has tracked his fuel economy across all 43,497 miles he’s driven in his 2021 Mazda3 over the past
Read MoreIn San Francisco, the signs that Tech Week had arrived were hard to miss. Planes towed banners advertising startups above
Read MoreJacob Coxon, the poster child for AI doom and gloom, said there’s a reason that pacing the frontier may not
Read MoreDarren Ellis and his older brother were the first in their family to go to university. It didn’t take him
Read MoreAnthropic has a secret to its success, says one of its earliest investors: the aura of curly-haired CEO Dario Amodei.
Read MoreLime CEO Wayne Ting needed brain surgery to survive a serious stroke. Less than two years later, he’s navigated his
Read MoreShares of Constellation Energy (CEG -0.27%) rallied on news that it had agreed to a deal that will bring 890
Read MoreAmazon employees reported a new round of job cuts across several parts of the company on Tuesday. A group of
Read More